ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
44 announcements
Nephrocare reports strong FY26 performance with 32% revenue growth and significant margin expansion, driven by international expansion and platform-led operational efficiencies.
Nephrocare Health Services incorporated a new wholly-owned step-down subsidiary in Kazakhstan. This ₹0.10 Crore investment supports the international expansion of its dialysis service network.
Nephrocare Health Services incorporated a new wholly-owned step-down subsidiary, NPHSK LLP, in Kazakhstan. The entity will expand kidney care and dialysis services into the region.
Nephrocare Health Services Limited's subsidiary acquired two dialysis centers in the Philippines for ₹11.24 Crore. This expansion strengthens its international presence and operational footprint.
Nephrocare Health Services appointed BDO India LLP as Internal Auditor for a twelve-month term. The move aims to strengthen internal controls and risk management practices.
Nephrocare Health Services (NephroPlus) reported strong FY26 performance with revenue reaching ₹998.8 Cr, driven by international expansion and increased treatment volumes.
Nephrocare Health Services reported FY26 revenue of ₹998.8 Crore, up 32.2% YoY. Growth was driven by international market expansion and increased treatment volumes.
Nephrocare Health Services Ltd reported revenue from operations of ₹265.6 Cr (+21.2% YoY) and net profit of ₹30.4 Cr (+22.1% YoY) for Q4 FY26.
Nephrocare Health Services approved its FY26 audited financial results and authorized up to Rs. 10 Crore investment in its Nepal subsidiary. The board also approved credit security support.
Nephrocare Health Services Limited submitted its quarterly Monitoring Agency Report for IPO proceeds utilization. Crisil Ratings confirmed ₹353.41 Crore was deployed toward expansion and debt repayment.
Nephrocare Health's subsidiary entered an agreement to acquire Orani Hemodialysis Center's assets for PHP 89.6 million. The deal expands the company's dialysis center network in Philippines.
Nephrocare Health Services Limited has scheduled a Board Meeting on May 19, 2026, to approve audited standalone and consolidated financial results for the fiscal year ended March 2026. The company's trading window remains closed until May 21, 2026.
Nephrocare Health Services Ltd has scheduled a Board of Directors meeting for May 19, 2026. The board will consider and approve audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The company's trading window remains closed until May 21, 2026.
Nephrocare Health Services Limited has designated its CFO, Mr. Prashant Vinodkumar Goenka, as the Chief Risk Officer with effect from April 03, 2026. Mr. Goenka brings over 20 years of experience from global financial institutions like HSBC and JP Morgan. This additional responsibility aims to strengthen the company's risk management framework.